Thrombotic microangiopathy in cancer
- 1 April 2018
- journal article
- conference paper
- Published by Elsevier in Thrombosis Research
- Vol. 164, S103-S105
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCTBone Marrow Transplantation, 2010
- VEGF Inhibition and Renal Thrombotic MicroangiopathyNew England Journal of Medicine, 2008
- TTP-HUS Associated with SunitinibCancer Research and Treatment, 2008
- Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndromeAnnals of Oncology, 2007
- Gemcitabine-induced thrombotic microangiopathy: a systematic reviewNephrology Dialysis Transplantation, 2006
- Tissue Factor in Infection and Severe InflammationSeminars in Thrombosis and Hemostasis, 2006
- Procoagulant Soluble Tissue Factor Is Released From Endothelial Cells in Response to Inflammatory CytokinesCirculation Research, 2005
- Sirolimus‐Induced Thrombotic Microangiopathy is Associated with Decreased Expression of Vascular Endothelial Growth Factor in KidneysAmerican Journal of Transplantation, 2005
- Homocysteine, Coagulation, Platelet Function, and ThrombosisSeminars in Thrombosis and Hemostasis, 2000
- Carboplatin-associated thrombotic microangiopathic hemolytic anemiaCancer, 1989